NCT05678699 The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity
| NCT ID | NCT05678699 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Severe Maternal Morbidity |
| Study Type | INTERVENTIONAL |
| Enrollment | 10,000,000 participants |
| Start Date | 2023-01-03 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10,000,000 participants in total. It began in 2023-01-03 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to learn about the effects of structural inventions, such as equity-focused Medicaid polices, on severe maternal morbidity (SMM) and mortality and maternal health. The main questions it aims to answer are: 1. What is the effect of Medicaid healthcare quality interventions on SMM? 2. What is the effect of Medicaid healthcare quality interventions + doula care? 3. What are Medicaid beneficiaries' experiences in receiving services and the potential impact of integration of doula services and equity practices? Participants will be asked to describe experiences as a result of structural interventions and focused Medicaid policies.
Eligibility Criteria
Inclusion Criteria: * Pregnant and postpartum Medicaid beneficiaries across the US Qualitative: * Medicaid beneficiaries who self-identify as Black and/or live in PA Health Equity Zones * Doulas who provide care to Medicaid beneficiaries in Pennsylvania * Medicaid Managed Care Organization (MCO) administrators in Pennsylvania. Severe maternal morbidity and mortality outcomes will be assessed in healthcare records and for these quantitative outcomes, patients will not be recruited individually Exclusion Criteria: \-
Frequently Asked Questions
Who can join the NCT05678699 clinical trial?
This trial is open to participants of all sexes, studying Severe Maternal Morbidity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05678699 currently recruiting?
Yes, NCT05678699 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Pittsburgh to inquire about joining.
Where is the NCT05678699 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT05678699 clinical trial?
NCT05678699 is sponsored by University of Pittsburgh. The trial plans to enroll 10,000,000 participants.